Asset Allocation
| Position | Category/Sector | Target Weight |
|---|---|---|
AVGO Broadcom Inc. | Technology | 3.50% |
LLY Eli Lilly and Company | Healthcare | 48.39% |
NVDA NVIDIA Corporation | Technology | 28.53% |
TSLA Tesla, Inc. | Consumer Cyclical | 3.08% |
UNH UnitedHealth Group Incorporated | Healthcare | 16.49% |
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Magnum Experiment 97D, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.
Loading graphics...
The earliest data available for this chart is Jun 29, 2010, corresponding to the inception date of TSLA
Returns By Period
As of Apr 11, 2026, the Magnum Experiment 97D returned -7.35% Year-To-Date and 44.57% of annualized return in the last 10 years.
| 1D | 1M | YTD | 6M | 1Y | 3Y* | 5Y* | 10Y* | |
|---|---|---|---|---|---|---|---|---|
Benchmark S&P 500 Index | -0.11% | 2.16% | -0.42% | 4.03% | 27.10% | 18.38% | 10.55% | 12.70% |
Portfolio Magnum Experiment 97D | 0.02% | 0.54% | -7.35% | 6.53% | 30.87% | 47.75% | 45.86% | 44.57% |
| Portfolio components: | ||||||||
AVGO Broadcom Inc. | 4.69% | 10.82% | 7.58% | 14.91% | 105.87% | 83.91% | 53.30% | 40.88% |
LLY Eli Lilly and Company | -1.65% | -3.87% | -12.44% | 13.07% | 29.22% | 38.18% | 39.87% | 31.00% |
NVDA NVIDIA Corporation | 2.57% | 3.00% | 1.15% | 3.00% | 70.08% | 90.83% | 67.37% | 71.10% |
TSLA Tesla, Inc. | 0.96% | -11.66% | -22.41% | -15.61% | 38.30% | 23.16% | 9.11% | 35.67% |
UNH UnitedHealth Group Incorporated | -0.84% | 9.85% | -7.09% | -12.90% | -47.80% | -14.75% | -2.50% | 10.95% |
Monthly Returns
Based on dividend-adjusted daily data since Jun 30, 2010, Magnum Experiment 97D's average daily return is +0.14%, while the average monthly return is +2.84%. At this rate, an investment would double in approximately 2.1 years.
Historically, 71% of months were positive and 29% were negative. The best month was Jan 2011 with a return of +17.7%, while the worst month was Jan 2022 at -11.9%. The longest winning streak lasted 12 consecutive months, and the longest losing streak was 4 months.
On a daily basis, Magnum Experiment 97D closed higher 56% of trading days. The best single day was Mar 13, 2020 with a return of +9.9%, while the worst single day was Mar 16, 2020 at -12.7%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -3.42% | -1.43% | -8.14% | 5.95% | -7.35% | ||||||||
| 2025 | 0.54% | 4.64% | -8.20% | 1.63% | -4.23% | 9.48% | -2.04% | 2.51% | 7.77% | 9.18% | 8.77% | 0.88% | 33.42% |
| 2024 | 11.12% | 17.28% | 6.40% | -1.36% | 10.39% | 10.56% | -4.06% | 9.48% | -2.47% | -1.20% | 1.74% | -2.81% | 67.05% |
| 2023 | 7.23% | 2.93% | 12.06% | 7.26% | 15.58% | 8.99% | 2.63% | 10.82% | -4.53% | 0.14% | 8.80% | 1.14% | 99.96% |
| 2022 | -11.92% | 0.92% | 12.65% | -9.22% | 3.70% | -2.43% | 8.64% | -10.23% | -3.05% | 10.39% | 8.72% | -6.23% | -2.13% |
| 2021 | 10.80% | 0.45% | -3.60% | 3.89% | 7.29% | 14.19% | 2.81% | 7.66% | -8.15% | 16.27% | 7.10% | 3.49% | 78.93% |
Benchmark Metrics
Magnum Experiment 97D has an annualized alpha of 23.47%, beta of 1.03, and R² of 0.57 versus S&P 500 Index. Calculated based on daily prices since June 30, 2010.
- This portfolio captured 162.44% of S&P 500 Index gains but only 48.00% of its losses — a favorable profile for investors.
- This portfolio generated an annualized alpha of 23.47% versus S&P 500 Index — delivering returns beyond what market exposure alone would predict.
- With beta of 1.03 and R² of 0.57, this portfolio moves broadly in line with S&P 500 Index — much of its variation is explained by market exposure rather than independent behavior.
- Alpha
- 23.47%
- Beta
- 1.03
- R²
- 0.57
- Upside Capture
- 162.44%
- Downside Capture
- 48.00%
Expense Ratio
Magnum Experiment 97D has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.
Return for Risk
Risk / Return Rank
Magnum Experiment 97D ranks 14 for risk / return — in the bottom 14% of portfolios on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
| Portfolio | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.34 | 2.23 | -0.89 |
Sortino ratioReturn per unit of downside risk | 1.84 | 3.12 | -1.28 |
Omega ratioGain probability vs. loss probability | 1.25 | 1.42 | -0.17 |
Calmar ratioReturn relative to maximum drawdown | 2.22 | 4.05 | -1.82 |
Martin ratioReturn relative to average drawdown | 7.32 | 17.91 | -10.59 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
How much return does each position deliver for the risk it carries? Higher values mean better reward for the risk taken.
| Risk / Return Rank | Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Martin ratio | |
|---|---|---|---|---|---|---|
AVGO Broadcom Inc. | 86 | 2.76 | 3.36 | 1.43 | 4.89 | 11.77 |
LLY Eli Lilly and Company | 51 | 0.76 | 1.26 | 1.18 | 1.00 | 2.43 |
NVDA NVIDIA Corporation | 81 | 2.19 | 2.75 | 1.34 | 4.75 | 11.78 |
TSLA Tesla, Inc. | 57 | 0.80 | 1.34 | 1.16 | 1.91 | 4.84 |
UNH UnitedHealth Group Incorporated | 8 | -0.93 | -1.17 | 0.81 | -0.72 | -0.94 |
Loading graphics...
Dividends
Dividend yield
Magnum Experiment 97D provided a 0.83% dividend yield over the last twelve months.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Portfolio | 0.83% | 0.74% | 0.63% | 0.67% | 0.85% | 0.87% | 1.22% | 1.38% | 1.41% | 1.56% | 1.77% | 1.79% |
| Portfolio components: | ||||||||||||
AVGO Broadcom Inc. | 0.67% | 0.70% | 0.94% | 1.71% | 3.02% | 2.24% | 3.05% | 3.54% | 3.11% | 1.87% | 1.43% | 1.13% |
LLY Eli Lilly and Company | 0.66% | 0.56% | 0.67% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.94% | 2.46% | 2.77% | 2.37% |
NVDA NVIDIA Corporation | 0.02% | 0.02% | 0.03% | 0.03% | 0.11% | 0.05% | 0.12% | 0.27% | 0.46% | 0.29% | 0.45% | 1.20% |
TSLA Tesla, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
UNH UnitedHealth Group Incorporated | 2.90% | 2.64% | 1.62% | 1.38% | 1.21% | 1.12% | 1.38% | 1.41% | 1.38% | 1.30% | 1.48% | 1.59% |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Magnum Experiment 97D. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Magnum Experiment 97D was 26.75%, occurring on Mar 23, 2020. Recovery took 17 trading sessions.
The current Magnum Experiment 97D drawdown is 9.46%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -26.75% | Feb 20, 2020 | 23 | Mar 23, 2020 | 17 | Apr 16, 2020 | 40 |
| -21.15% | May 13, 2011 | 60 | Aug 8, 2011 | 162 | Mar 29, 2012 | 222 |
| -20.18% | Oct 5, 2018 | 55 | Dec 24, 2018 | 59 | Mar 21, 2019 | 114 |
| -19.82% | Oct 15, 2024 | 118 | Apr 4, 2025 | 110 | Sep 12, 2025 | 228 |
| -18.5% | Dec 28, 2021 | 22 | Jan 27, 2022 | 41 | Mar 28, 2022 | 63 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Diversification
Diversification Metrics
Number of Effective Assets
The portfolio contains 5 assets, with an effective number of assets of 2.90, reflecting the diversification based on asset allocation. This number of effective assets suggests a highly concentrated portfolio, where a few assets dominate the allocation, potentially increasing the portfolio's risk due to lack of diversification.
Asset Correlations Table
| Benchmark | UNH | TSLA | LLY | AVGO | NVDA | Portfolio | |
|---|---|---|---|---|---|---|---|
| Benchmark | 1.00 | 0.47 | 0.46 | 0.43 | 0.62 | 0.60 | 0.69 |
| UNH | 0.47 | 1.00 | 0.16 | 0.32 | 0.25 | 0.22 | 0.47 |
| TSLA | 0.46 | 0.16 | 1.00 | 0.14 | 0.37 | 0.39 | 0.41 |
| LLY | 0.43 | 0.32 | 0.14 | 1.00 | 0.24 | 0.22 | 0.71 |
| AVGO | 0.62 | 0.25 | 0.37 | 0.24 | 1.00 | 0.57 | 0.55 |
| NVDA | 0.60 | 0.22 | 0.39 | 0.22 | 0.57 | 1.00 | 0.76 |
| Portfolio | 0.69 | 0.47 | 0.41 | 0.71 | 0.55 | 0.76 | 1.00 |